Pitto Rocco P, Young Simon
Department of Orthopaedic Surgery, Middlemore Hospital, South Auckland Clinical School, University of Auckland, Auckland, New Zealand.
Int Orthop. 2008 Jun;32(3):331-6. doi: 10.1007/s00264-007-0326-9. Epub 2007 Feb 15.
Mechanical prophylaxis with foot pumps provides an interesting alternative to chemical agents in the prevention of thromboembolic disease following major orthopaedic surgical procedures. Recent studies have suggested that the simultaneous use of graduated compression stockings (GCS) may hinder the pneumatic compression effect of foot pumps. The hypothesis of this prospective study was that the use of foot pumps without GCS does not affect the efficacy of deep-vein thrombosis (DVT) prophylaxis and improves patient compliance. A total of 846 consecutive patients admitted at a single institution undergoing total hip (THR) or knee replacement (TKR) were included in the study. The A-V Impulse System foot-pump unit (Orthofix Vascular Novamedix, Andover, UK) was used in all patients. Of these 846 patients, 46 discontinued the use of foot pumps, leaving 400 patients who received foot pumps in combination with GCS and 400 patients with foot pumps alone. Eleven patients of the stocking group (2.7%) and nine patients of the no-stocking group (2.3%) developed postoperative symptomatic DVT (p=0.07). DVT was more frequent in TKR (10/364; 2.7%) than in THR (10/436; 2.3%). Non-fatal pulmonary embolism occurred in four of the 20 patients with symptomatic DVT, two patients each of the stocking and no-stocking groups. The foot-pump discontinuation rate of patients treated with stockings was 7% versus 4% of the patients treated without stockings (p<0.05). In conclusion, management of patients with foot pumps without GCS does not reduce the efficacy of DVT prophylaxis after THR and TKR and improves patient compliance.
在预防重大骨科手术后的血栓栓塞性疾病方面,使用足部泵进行机械预防为化学药物提供了一种有趣的替代方法。最近的研究表明,同时使用梯度压力弹力袜(GCS)可能会妨碍足部泵的气动压缩效果。这项前瞻性研究的假设是,不使用GCS而使用足部泵不会影响深静脉血栓形成(DVT)预防的效果,并且能提高患者的依从性。该研究纳入了在单一机构连续收治的846例接受全髋关节置换(THR)或膝关节置换(TKR)的患者。所有患者均使用A-V脉冲系统足部泵装置(英国安多弗的Orthofix Vascular Novamedix公司生产)。在这846例患者中,46例停止使用足部泵,剩下400例患者同时接受足部泵和GCS治疗,400例患者仅接受足部泵治疗。弹力袜组有11例患者(2.7%),无弹力袜组有9例患者(2.3%)发生了术后有症状的DVT(p = 0.07)。DVT在TKR患者中(10/364;2.7%)比在THR患者中(10/436;2.3%)更常见。20例有症状DVT患者中有4例发生了非致命性肺栓塞,弹力袜组和无弹力袜组各2例。接受弹力袜治疗的患者足部泵停用率为7%,而未接受弹力袜治疗的患者为4%(p<0.05)。总之,不使用GCS而使用足部泵对患者进行管理,在THR和TKR后不会降低DVT预防的效果,并且能提高患者的依从性。